AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.
Textmine is an E2E AI powered knowledge base for your business critical documents (things like invoices, payslips, tender documents, compliance reports and even contracts). We consolidate everything into a single operational layer to enable proactive decision making. We give Increased data transparency, whilst allowing document creation to be more scalable and uniform. We’ve helped organisations save money and time whilst reducing their risk profile and increasing compliance.
Opsydia is set to disrupt a number of industries by its ability to create practically invisible structures inside transparent materials. Permanent and inimitable serial numbers, images or cryptographic data can be laser-written without compromising the integrity of the material or modifying its surface. Material applications include diamond, glass and polymers
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking. It is hoped that Ceryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury.
Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering from impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of the hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy. The company develops both cell therapy and small molecule therapeutics primarily targeting cancer.
SERG Technologies is re-defining the way we interact with technology by creating reliable and functional wearables that can be used for activity tracking, monitoring health and fitness, and gesture recognition for smart devices. Our unique sensors detect tiny, subconscious movements that indicate a wearer’s intent, we turn these into control signals for everything from TV’s to smart prosthetics, resulting in almost instant response times. We are also developing new tools to allow Parkinson's patients to track their symptoms, providing vital new information to their doctors, leading to long term improvements to the efficacy their treatment. SERG was founded to make the gesture control of technology accessible for everyone and easier to use than ever before.
BibliU provides colleges and universities with digital content management, automation, and analytics platform. BibliU’s solution puts digital textbooks, courseware, and monographs at the fingertips of all students. Working with thousands of publishers and OER providers to deliver millions of digital resources, BibliU combines academic freedom with innovative affordability and automation.
Sano Genetics is a health technology company that focuses on personalized medicine and genetics. They aim to empower individuals to contribute their genetic and health data for research purposes, with the goal of advancing scientific understanding and personalized approaches to healthcare. Sano Genetics often operates within the context of genetic research studies and projects, allowing participants to share their genetic information to contribute to the broader field of medical research
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. Semarion combines microchip industry materials and techniques engineering and cell biology to tackle unmet drug screening needs.
Paragraf produces graphene electronic devices using contamination-free technology to deliver commercial-quality products. The company aims to significantly transform the electronics industry by developing high-purity graphene products that enhance technological performance. Paragraf is committed to driving material advancements in electronics through its innovative approach.
Barocal is a Zero-carbon refrigeration.
Bramble Energy is an innovator energy technology company that designs and manufactures high-performance, low-cost, and fuel cell stack. The company ability to leverage the global high-volume PCB industry means that they are the first fuel cell company with the manufacturing capacity to supply gigawatts of fuel cell hardware, something the battery industry has spent many years and £B’s to achieve. Bramble Energy specifically uses a printed circuit board (PCB) technology to form the structural parts of the fuel cell. It also provides products including modular PCBFC stacks, H20:20W PCBFC system, custom design PCBFC, and 500W PCBFC stack. Bramble Energy was founded in 2016 and is based in London, England, United Kingdom.
Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128 billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™.
Sano Genetics is a health technology company that focuses on personalized medicine and genetics. They aim to empower individuals to contribute their genetic and health data for research purposes, with the goal of advancing scientific understanding and personalized approaches to healthcare. Sano Genetics often operates within the context of genetic research studies and projects, allowing participants to share their genetic information to contribute to the broader field of medical research
Paragraf produces graphene electronic devices using contamination-free technology to deliver commercial-quality products. The company aims to significantly transform the electronics industry by developing high-purity graphene products that enhance technological performance. Paragraf is committed to driving material advancements in electronics through its innovative approach.
Cambridge Touch Technologies, Ltd. develops next-generation UltraTouch technology for smart devices such as smartphones, tablets, automotive and industrial applications. Combining a proprietary AI engine running sophisticated signal processing algorithms with an advanced Piezoelectric Force Film, UltraTouch enables the world’s simplest all-in-one touch and force sensor architecture that delivers superior functionality at lower cost, and scales to all device sizes and shapes (including curved and foldable)
Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests. The company is a spin-out of the AI research group at Oxford, its automated code-writing capability has far-reaching potential and will eventually transform how software is written. Initially, Diffblue’s technology was deployed to save developers time and ensure robustness in one of software development's most tedious and time-consuming areas: writing unit tests. Diffblue's product stands out from code suggestion tools in that it works completely autonomously, using reinforcement learning to write fully formed tests that are guaranteed to compile, run, and find bugs.
Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications such as bypassing peripheral blockages and in vascular access creation for dialysis patients, which represents a £1.6b yearly market.
Fuel3D is an affordable handheld 3D scanning system that delivers extremely high quality 3D shape and color capture for a range of creative applications. The Fuel3D handheld scanner is a point-and-shoot 3D scanning system that captures extremely high resolution mesh and color information of objects. Fuel3D is the world’s first 3D scanner to combine pre-calibrated stereo cameras with photometric imaging to capture and process files in seconds. But generating high quality 3D images for use in 3D printing or gaming is typically time-consuming and expensive. A handheld 3D scanner today can cost upwards of $15,000, pricing them well above what most independent game developers, designers and artists can afford. Born in Oxford University, Fuel3D is developed by an expert team of hardware and software engineers and scientists. Originally developed for the medical imaging sector, Fuel3D’s technology is being adapted for the broader 3D market, with the goal of bringing the benefits of point-and-shoot 3D imaging to consumers and professionals alike. Originally developed by Professor Ron Daniel, Lecturer in Engineering Science at Oxford University, Fuel3D is today led by Stuart Mead, CEO, a veteran of several successful global technology ventures.
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Charco Neurotech is a medical technology company that develops non-invasive wearable devices.
Carbon Re is a climate technology company developing artificial intelligence to decarbonize energy-intensive industries. It intends to use AI technology to reduce carbon emissions by gigatonnes per year. Its emphasis is on energy-intensive industries like cement, steel, and glass, which account for more than 20% of global emissions. Deep learning is used by Carbon Re's Delta Zero platform for industrial decarbonization to enable rapid development and deployment of new low-carbon industrial processes, designs, and materials.
Cheesecake Energy is developing advanced thermal and compressed air energy systems to store energy from intermittent renewables, turning them into reliable power on-demand.
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.
Helio develops materials for a new generation of brighter, more colorful displays. Helio's materials can display richer, less filtered colors, resulting in a better overall visual experience while using significantly less power. Helio is on a mission to improve display performance and efficiency through the use of perovskite science. In order to speed up sound research and development, they collaborate with the scientific and business minds in their industry.
Nyobolt is a developer of high-power battery technology used to serve automotive applications. It researches and develops battery technology that could have a higher power, recharge at a faster speed and store large amounts of energy that helps the automotive industry with solutions for high-power applications. The company was founded in 2020 and is based in Cambridge, United Kingdom.
Nozzle.ai is an eCommerce and advertising optimization platform for Amazon. Nozzle.ai delivers direct-to-consumer level insights about customers on Amazon to beat the competition and grow businesses. Nozzle.ai aims to simplify the selling experience on Amazon.
Echion Technologies specializes in developing advanced anode materials for Li-ion batteries. Their XNO® material boasts faster charging times, longer lifespans, and improved safety compared to traditional options. Echion targets the heavy-duty electric vehicle market, aiming to improve efficiency and sustainability within the transportation sector.
Bonnet aims to reduce the headache associated with drivers having to register separately for individual public charging networks to charge their car. Instead, we provide a service for drivers and businesses that allows them to use any public charger with just one app.
Private Equity Round in 2021
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.
Fresh Check is a simple sticker that you put inside the packaging of food that changes colour when your food has actually gone off, not when the use-by date says so.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.
Versed AI helps companies to monitor, manage, and mitigate supply chain risks and identify constituents of their supply chains. It is through using cutting-edge natural language processing (NLP) techniques and Machine Learning (ML) to extract buyer-supplier relationships from text documents and aggregate this into a large supply chain map. It is founded by Simon Baker and Fenelle Boyle.
Mach42 is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. The platforms can be used to enhance existing stem-cell forward programming methods, or bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications.
iKVA is an AI knowledge management software company.
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.
Abselion is the biological sensor for rapid and cost-effective detection of biological substances like proteins, DNA, or small molecules.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Carbometrics is a specialist chemistry company .Our core competency is the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules. Our technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Carbometrics’ goal is to exploit our GBM technology to realise a highly robust and accurate glucose sensing platform that can be used to create a market-leading Continuous Glucose Monitoring (CGM) solution. The company was set up after the founders sold their first company Ziylo to Novo Nordisk, which is using the same platform to develop smart insulins.
Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering from impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of the hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savings onto patients.
Riverlane creates and engineers instruments. With the help of the manufacturers of quantum computers, they put them into practice. New hardware and software tools are needed to regulate intrinsically unstable qubits and completely fix system defects ten billion times or more per second in order to unlock the entire range of quantum computing applications.
Entia is a medical technology company that specializes in improving access to blood tests. Its featured products include Aptus, designed for haemoglobin and haematocrit and Affinity, designed for people with cancer to monitor their blood counts at home. The company is a multidisciplinary team spanning design, engineering, quality assurance, business development, and innovation.
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.
Textmine is an E2E AI powered knowledge base for your business critical documents (things like invoices, payslips, tender documents, compliance reports and even contracts). We consolidate everything into a single operational layer to enable proactive decision making. We give Increased data transparency, whilst allowing document creation to be more scalable and uniform. We’ve helped organisations save money and time whilst reducing their risk profile and increasing compliance.
Cambridge GaN Devices focuses on the development of gallium nitride power devices that enhance energy efficiency in electronic applications. The company offers a range of GaN-based semiconductor products designed to improve power conversion and reduce energy loss in various systems. These devices are utilized in sectors such as renewable energy, electric vehicles, and consumer electronics, contributing to the advancement of greener technologies. Cambridge GaN Devices collaborates with industry partners to drive innovation and facilitate the adoption of its technology in the power semiconductor market.
Mirriad’s award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad’s market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions. Mirriad currently operates in the US, Europe and China.
Phasecraft is a group of world-class quantum scientists and engineers who are tackling grand challenges by expediting the practical application of quantum computing. The company envisions a world in which breakthrough scientific discoveries are commonplace, allowing entrepreneurs to address the world's most pressing concerns more quickly.
NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market. The company specializes in rapid set liquid barriers.
Nozzle.ai is an eCommerce and advertising optimization platform for Amazon. Nozzle.ai delivers direct-to-consumer level insights about customers on Amazon to beat the competition and grow businesses. Nozzle.ai aims to simplify the selling experience on Amazon.
Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
1715Labs is a company being established to commercialise Zooniverse technology.
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.
GeoSpock enables data fusion for the connected world with GeoSpock DB – the space-time analytics database. GeoSpock DB is a unique, cloud-native database optimised for querying for real-world use cases, able to fuse multiple sources of Internet of Things (IoT) data together to unlock its full value, whilst simultaneously reducing complexity and cost. GeoSpock DB enables efficient storage, data fusion, and rapid programmatic access to data, and allows you to run ANSI SQL queries and connect to standard analytics tools via flexible JDBC/ODBC connectors. Users are able to perform deep analysis and share insights using familiar toolsets, with plug and play support for common BI tools (such as Tableau™, Amazon QuickSight™, and Microsoft Power BI™), and Data Science and Machine Learning environments (including Python Notebooks and Apache Spark). The database can also be integrated with proprietary applications, web services, and internal tools – with compatibility for open-source and customisable visualisation libraries such as Kepler and Cesium.js.
Nyobolt is a developer of high-power battery technology used to serve automotive applications. It researches and develops battery technology that could have a higher power, recharge at a faster speed and store large amounts of energy that helps the automotive industry with solutions for high-power applications. The company was founded in 2020 and is based in Cambridge, United Kingdom.
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking. It is hoped that Ceryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury.
Nu Quantum is building the quantum networking infrastructure essential to scaling quantum computers, by interconnecting quantum computing cores into large distributed clusters. We are creating full hardware solutions to create entangled qubit networks, including a unique high-speed computer network interface, photonic switching fabric, and control systems to accelerate the roadmap towards multi-core quantum supercomputers and quantum data centres. Partnering with leading QC companies, governments and research groups, we seek to bring this technology to market.
GaitQ is a developer of a medical device used to help people living with Parkinson's disease to overcome freezing of gait. Its small, portable device uses clinically proven sensory cues that enable patients to re-establish the connection between the brain and the body helps the patients to walk smoothly again.
Bramble Energy is an innovator energy technology company that designs and manufactures high-performance, low-cost, and fuel cell stack. The company ability to leverage the global high-volume PCB industry means that they are the first fuel cell company with the manufacturing capacity to supply gigawatts of fuel cell hardware, something the battery industry has spent many years and £B’s to achieve. Bramble Energy specifically uses a printed circuit board (PCB) technology to form the structural parts of the fuel cell. It also provides products including modular PCBFC stacks, H20:20W PCBFC system, custom design PCBFC, and 500W PCBFC stack. Bramble Energy was founded in 2016 and is based in London, England, United Kingdom.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
Bramble Energy is an innovator energy technology company that designs and manufactures high-performance, low-cost, and fuel cell stack. The company ability to leverage the global high-volume PCB industry means that they are the first fuel cell company with the manufacturing capacity to supply gigawatts of fuel cell hardware, something the battery industry has spent many years and £B’s to achieve. Bramble Energy specifically uses a printed circuit board (PCB) technology to form the structural parts of the fuel cell. It also provides products including modular PCBFC stacks, H20:20W PCBFC system, custom design PCBFC, and 500W PCBFC stack. Bramble Energy was founded in 2016 and is based in London, England, United Kingdom.
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking. It is hoped that Ceryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury.
Mind Foundry is an Oxford University Company. Operating at the intersection of innovation and usability, Mind Foundry empowers organisations through the use of Responsible AI built to tackle high-stakes, real-world problems at both individual and population scale. Mind Foundry’s AI Platform and technologies have been used to solve some of the most challenging applications of Machine Learning, from insurance fraud detection to complex signal processing, helping customers in insurance, infrastructure, and defence and security tackle the issues that matter most to them whilst promoting the responsible and transparent usage of AI. Founded by pioneers in the field of AI and Machine Learning, Oxford Professors Stephen Roberts and Michael Osborne, the mission of Mind Foundry is to create a future where humans and AI work together to solve the world’s most important problems.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, UK, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cultivated meat sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF (NK1). Qkine is an ISO 9001: 2015 certified company.
Flusso is a semiconductor company that develops and manufactures sensor solutions for various industries. It provides and offers mass flow and air velocity sensors for proprietary technology uses. Flusso was founded in 2016 and is based in Cambridge, UK.
Oxford Flow combines the finest minds from academia with global expertise from industry to deliver practical solutions that enable their customers to make their operations quicker and slicker while reducing environmental impact. Oxford Flow is able to save you money without sacrificing performance. Every device is the result of intensive testing and customer feedback. Their solutions aren’t just theoretical - they are proven in the harshest of conditions to work time after time.
Fuel3D is an affordable handheld 3D scanning system that delivers extremely high quality 3D shape and color capture for a range of creative applications. The Fuel3D handheld scanner is a point-and-shoot 3D scanning system that captures extremely high resolution mesh and color information of objects. Fuel3D is the world’s first 3D scanner to combine pre-calibrated stereo cameras with photometric imaging to capture and process files in seconds. But generating high quality 3D images for use in 3D printing or gaming is typically time-consuming and expensive. A handheld 3D scanner today can cost upwards of $15,000, pricing them well above what most independent game developers, designers and artists can afford. Born in Oxford University, Fuel3D is developed by an expert team of hardware and software engineers and scientists. Originally developed for the medical imaging sector, Fuel3D’s technology is being adapted for the broader 3D market, with the goal of bringing the benefits of point-and-shoot 3D imaging to consumers and professionals alike. Originally developed by Professor Ron Daniel, Lecturer in Engineering Science at Oxford University, Fuel3D is today led by Stuart Mead, CEO, a veteran of several successful global technology ventures.
Quantum Motion Technologies is building a universal quantum computer in Silicon, using CMOS compatible processes.
PervasID is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.
Their sensors are based on film bulk acoustic resonator (FBAR) technology. The devices, fabricated on a silicon wafer, comprise a thin film of piezoelectric material that is made to resonate. Attachment of mass to the surface changes the resonant frequency and provides an extremely accurate measurement of the amount of mass on the sensing area.Their sensors are suited to applications where you need to detect small masses in a device with an extremely small form factor. Functionalising the surface of their devices means that they can selectively detect specific targets.
Xampla is a cleantech company that creates plant protein material for commercial use. Its materials include microcapsules, beads, films, threads, and other structures made from plant protein with biodegradable, biocompatible, and no synthetic ingredients used for food, cosmetics, household products, animal feed, packaging, and medical applications.
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery of vital new medicines.
Ilika accelerates the development of new materials for energy and electronics applications through the use of its patented, high throughput techniques. Ilika’s technology enables functional materials to be made, characterised and tested up to 100 times faster than traditional techniques. Ilika has commercial partnerships with international blue-chip companies.
Audiotelligence leads the world in blind audio signal separation from multi-microphone captured audio. Our AudioTelligence nD technologies greatly out-perform existing 'state-of-the art' commercially available technologies such as beam forming, spectral masking, deep neural nets, non-negative matrix factorisation and ICA.
Echion Technologies specializes in developing advanced anode materials for Li-ion batteries. Their XNO® material boasts faster charging times, longer lifespans, and improved safety compared to traditional options. Echion targets the heavy-duty electric vehicle market, aiming to improve efficiency and sustainability within the transportation sector.
Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.
Cambridge Photon Technology is a developer of organic photovoltaic devices used to enhance next-generation solar technology. Its devices engage in the deployment of off-grid solar power and use advanced nanotechnology to split each incoming blue and green photon into two infra-red photons that enable clients to deploy solar power through lightweight devices whenever needed.
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.
RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI. The company develops innovative, privacy-preserving, and cost-effective technology to maximise the value of industrial CCTV cameras. RoboK is already working with some of the largest critical infrastructure operators, turning their on-site visual data into high-value actionable insights.
Paragraf produces graphene electronic devices using contamination-free technology to deliver commercial-quality products. The company aims to significantly transform the electronics industry by developing high-purity graphene products that enhance technological performance. Paragraf is committed to driving material advancements in electronics through its innovative approach.
Entia is a medical technology company that specializes in improving access to blood tests. Its featured products include Aptus, designed for haemoglobin and haematocrit and Affinity, designed for people with cancer to monitor their blood counts at home. The company is a multidisciplinary team spanning design, engineering, quality assurance, business development, and innovation.
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.
LettUs Grow is a team of growers, engineers, plant scientists, software developers and business experts, who all care deeply about food and the environment. Together we design and build aeroponic technology and farm management software for greenhouse and vertical farms. We believe careful innovation in farming can make the world a better place. Our technology reduces the environmental impact of agriculture and makes farmers’ lives easier. We are dedicated to making sustainable farming a sustainable business.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
Nozzle.ai is an eCommerce and advertising optimization platform for Amazon. Nozzle.ai delivers direct-to-consumer level insights about customers on Amazon to beat the competition and grow businesses. Nozzle.ai aims to simplify the selling experience on Amazon.
Inflowmatix is a spin-out company from the InfraSense Labs at the Department of Civil and Environmental Engineering of Imperial College London. Inflowmatix builds upon the unique cross-disciplinary expertise from sensing to advanced modelling and optimization and the active research collaborations with water utilities and IT system integrators. Inflowmatix creates innovative and customer tailored solutions for the steady-state, resilient and energy efficient operation of water supply networks by continuously monitoring and analyzing the fluid dynamics in complex networks. This allows operators to continuously gain unique insight and proactively optimize the dynamic network performance in order to extend the service life of infrastructure assets. Our expertise in modelling the steady and unsteady-state hydraulics of water distribution networks, combined with knowledge and experience in the design and implementation of embedded electronic systems, yield compelling returns on investment for our customers. Many cities in the world face the problem of ageing infrastructure, increasing population demand and climate change. This combined with increasing regulatory and financial pressure means water utilities are actively seeking novel, integrated and optimized operational strategies for managing leakage, demand and energy efficiency in order to deliver high-quality of service to customers within cost constraints. Water companies and operators are facing unparalleled challenges to meet increasing demand with limited water and financial resources. By successfully applying the technologies and analytics developed by Inflowmatix to water supply networks, we significantly improve the management of leakage, demand, energy and operational incidents, thus providing multiple operational benefits for network operators.
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. The platforms can be used to enhance existing stem-cell forward programming methods, or bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications.
Covatic is a Birmingham and Oxford start-up exploring the use of mobile based algorithms to bring smart personalisation to apps. We are a small team of enthusiastic problem solvers, who are always looking for like-minded people to join us and take our products to the next level.
Echopoint Medical Ltd is developing a family of optical-fibre based sensors which integrate into medical innovative devices: bringing unparalleled sensing modalities to minimally-invasive procedures.Echopoint Medical Ltd (EML) is a medical device company focused on transforming precision diagnosis and treatment of cardiovascular disease. A spin-out from the University College London, we are translating breakthroughs in fibre optic sensor technology to address key unmet needs of patients, clinicians, and healthcare providers.